Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in ...

A groundbreaking lung cancer vaccine will be tested on humans from summer 2026, with British scientists working on jabs for ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Some cancer patients at The University of Texas MD Anderson Cancer Center got an unexpected boost. After receiving the ...

With enrollment completed and encouraging immune response and safety data observed in the Phase 1 trial, Anixa plans to advance the vaccine into a Phase 2 clinical trial and has assumed full ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...

Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcutaneous (under the skin) injections of programmed death ligand 1 (PD-L1) blocker called ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Becomes available free of charge for nine-year-old girls at EPI centres; other provinces expected to follow suit.

The study showed that women who received at least one dose of the quadrivalent HPV vaccine had a 37 per cent lower incidence ...

PD-1 inhibitors belong to a class of medications known as immune checkpoint inhibitors, which have become an important part of many modern cancer treatment plans. PD-1 inhibitors work by helping the ...